SYS ONLINE
Supplements/Fatty Acid

Evening Primrose Oil

aka EPO · GLA

Omega-6 source rich in GLA, used for atopic dermatitis and cyclical breast pain.

Buy

Overview

Omega-6 source rich in GLA, used for atopic dermatitis and cyclical breast pain.

Natural sources
  • Oenothera biennis seeds
Common forms
  • EPO standardized to GLA

Mechanism of action

GLA converts to DGLA, producing anti-inflammatory PGE1.

Pathways
  • · PGE1 synthesis

Effects on the body

Supports
Skin barrier
Decreases
Cyclical breast pain (mild)

Organ system effects

Skin

Mixed evidence in atopic dermatitis.

Evidence-based benefits

Modest improvement in cyclical breast pain

Limited evidence

Mixed for atopic dermatitis

Limited evidence

Potential side effects

Common
  • · GI upset
Rare
    Serious

      Drug interactions

      Anticoagulants
      Mild antiplatelet.
      minor
      Antiseizure drugs
      May lower threshold.
      moderate

      Supplement interactions

      Pairs well with
      • Collagen peptides
        Provides amino acid substrate for connective tissue synthesis.
      • Vitamin C
        Required cofactor for collagen hydroxylation.
      Avoid combining with

      No specific avoidances listed.

      Dosing & bioavailability

      Typical dose
      1000–3000 mg/d (8–10% GLA)
      Best form
      Most evidence is based on the epo standardized to gla form.
      Timing
      Consistent daily timing recommended; split larger doses if GI tolerance is a concern.
      With food?
      Either with or without food.

      Where to buy

      Affiliate links — we may earn a commission at no extra cost to you. Amazon code supplementsch-20 is auto-applied at checkout. We don't endorse specific brands; verify third-party testing (USP, NSF, Informed Sport) before purchase.

      Scientific evidence9Show studies
      Systematic reviewAltern Med Rev · 2010

      Evening primrose oil for mastalgia and PMS

      Pruthi S, et al.

      Review of EPO trials in breast pain and PMS.

      Key findings

      Limited efficacy beyond placebo; safe profile.

      Open study
      Systematic reviewPubMed (NLM) · 1970

      PubMed: Evening Primrose Oil — Modest improvement in cyclical breast pain

      Live PubMed search

      Live results for "Evening Primrose Oil Modest improvement in cyclical breast pain" across the PubMed/MEDLINE peer-reviewed index.

      Key findings

      Opens current human and preclinical literature matching Evening Primrose Oil and "Modest improvement in cyclical breast pain". Filter by RCT, meta-analysis, or year on the results page.

      Open study
      Systematic reviewPubMed (NLM) · 1970

      PubMed: Evening Primrose Oil — Mixed for atopic dermatitis

      Live PubMed search

      Live results for "Evening Primrose Oil Mixed for atopic dermatitis" across the PubMed/MEDLINE peer-reviewed index.

      Key findings

      Opens current human and preclinical literature matching Evening Primrose Oil and "Mixed for atopic dermatitis". Filter by RCT, meta-analysis, or year on the results page.

      Open study
      Systematic reviewPubMed (NLM) · 1970

      PubMed: Evening Primrose Oil — randomized controlled trial

      Live PubMed search

      Live results for "Evening Primrose Oil randomized controlled trial" across the PubMed/MEDLINE peer-reviewed index.

      Key findings

      Opens current human and preclinical literature matching Evening Primrose Oil and "randomized controlled trial". Filter by RCT, meta-analysis, or year on the results page.

      Open study
      Systematic reviewPubMed (NLM) · 1970

      PubMed: Evening Primrose Oil — meta-analysis

      Live PubMed search

      Live results for "Evening Primrose Oil meta-analysis" across the PubMed/MEDLINE peer-reviewed index.

      Key findings

      Opens current human and preclinical literature matching Evening Primrose Oil and "meta-analysis". Filter by RCT, meta-analysis, or year on the results page.

      Open study
      Systematic reviewPubMed (NLM) · 1970

      PubMed: Evening Primrose Oil — pharmacokinetics

      Live PubMed search

      Live results for "Evening Primrose Oil pharmacokinetics" across the PubMed/MEDLINE peer-reviewed index.

      Key findings

      Opens current human and preclinical literature matching Evening Primrose Oil and "pharmacokinetics". Filter by RCT, meta-analysis, or year on the results page.

      Open study
      Systematic reviewPubMed (NLM) · 1970

      PubMed: Evening Primrose Oil — safety adverse events

      Live PubMed search

      Live results for "Evening Primrose Oil safety adverse events" across the PubMed/MEDLINE peer-reviewed index.

      Key findings

      Opens current human and preclinical literature matching Evening Primrose Oil and "safety adverse events". Filter by RCT, meta-analysis, or year on the results page.

      Open study
      Systematic reviewPubMed (NLM) · 1970

      PubMed: Evening Primrose Oil — dose response

      Live PubMed search

      Live results for "Evening Primrose Oil dose response" across the PubMed/MEDLINE peer-reviewed index.

      Key findings

      Opens current human and preclinical literature matching Evening Primrose Oil and "dose response". Filter by RCT, meta-analysis, or year on the results page.

      Open study
      Systematic reviewGoogle Scholar · 1970

      Google Scholar: Evening Primrose Oil — clinical evidence

      Live Scholar search

      Cross-database citation index for Evening Primrose Oil as it relates to "clinical evidence".

      Key findings

      Includes preprints, theses, and journal articles. Useful for tracking citation counts and follow-on work.

      Open study
      Educational use only. This profile is not medical advice. Consult a qualified healthcare professional before starting any supplement, especially if you take prescription medication or have a chronic condition.

      Community discussion

      (0 threads)

      Share your experience or read what others have tried. Anecdotes are not medical advice.

      Sign in or create a free account to post or reply.
      Loading discussion…